Literature DB >> 22280867

Maternal mortality from preeclampsia/eclampsia.

Labib Ghulmiyyah1, Baha Sibai.   

Abstract

Preeclampsia/eclampsia is one of the 3 leading causes of maternal morbidity and mortality worldwide. During the past 50 years, there has been a significant reduction in the rates of eclampsia, maternal mortality, and maternal morbidity in the developed countries. In contrast, the rates of eclampsia, maternal complications, and maternal mortality remain high in the developing countries. These differences are mainly due to universal access to prenatal care, access to timely care, and proper management of patients with preeclampsia-eclampsia in the developed countries. In contrast, most of maternal deaths and complications are due to lack of prenatal care, lack of access to hospital care, lack of resources, and inappropriate diagnosis and management of patients with preeclampsia-eclampsia in the developing countries. Preeclampsia/eclampsia is associated with substantial maternal complications, both acute and long-term. Clear protocols for early detection and management of hypertension in pregnancy at all levels of health care are required for better maternal as well as perinatal outcome. This is especially important in the developing countries.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22280867     DOI: 10.1053/j.semperi.2011.09.011

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  178 in total

1.  Acute Cardiac Effects of Severe Pre-Eclampsia.

Authors:  Arthur Jason Vaught; Lara C Kovell; Linda M Szymanski; Susan A Mayer; Sara M Seifert; Dhananjay Vaidya; Jamie D Murphy; Cynthia Argani; Anna O'Kelly; Sarah York; Pamela Ouyang; Monica Mukherjee; Sammy Zakaria
Journal:  J Am Coll Cardiol       Date:  2018-07-03       Impact factor: 24.094

2.  Melanocortin-4 Receptor Deficiency Attenuates Placental Ischemia-Induced Hypertension in Pregnant Rats.

Authors:  Frank T Spradley; Ana C Palei; Christopher D Anderson; Joey P Granger
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

3.  Another good reason to recommend low-dose aspirin.

Authors:  Sonia Oyola; Katherine Kirley
Journal:  J Fam Pract       Date:  2015-05       Impact factor: 0.493

Review 4.  The forgotten father in obstetric medicine.

Authors:  A Kothari; K Thayalan; J Dulhunty; L Callaway
Journal:  Obstet Med       Date:  2019-02-18

5.  Temporal Trends of Hospitalization, Mortality, and Financial Impact Related to Preeclampsia with Severe Features in Hawai'i and the United States.

Authors:  Ji Hae Lee; Guangxiang Zhang; Scott Harvey; Kazuma Nakagawa
Journal:  Hawaii J Health Soc Welf       Date:  2019-08

6.  Association between cytokine profile and transcription factors produced by T-cell subsets in early- and late-onset pre-eclampsia.

Authors:  Vanessa R Ribeiro; Mariana Romao-Veiga; Graziela G Romagnoli; Mariana L Matias; Priscila R Nunes; Vera Therezinha M Borges; Jose C Peracoli; Maria Terezinha S Peracoli
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

7.  Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.

Authors:  C Li; N S Raikwar; M K Santillan; D A Santillan; C P Thomas
Journal:  Placenta       Date:  2015-01-17       Impact factor: 3.481

Review 8.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

9.  Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem/stromal cells and reduces their production of pro-inflammatory cytokines.

Authors:  Ramin Khanabdali; Aida Shakouri-Motlagh; Sarah Wilkinson; Padma Murthi; Harry M Georgiou; Shaun P Brennecke; Bill Kalionis
Journal:  J Mol Med (Berl)       Date:  2018-10-01       Impact factor: 4.599

10.  The patient-provider relationship and antenatal care uptake at two referral hospitals in Malawi: A qualitative study.

Authors:  J Roberts; D Sealy; H Hopp Marshak; L Manda-Taylor; P Gleason; R Mataya
Journal:  Malawi Med J       Date:  2015-12       Impact factor: 0.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.